|
Volumn 61, Issue 1, 2012, Pages 162-164
|
Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
AUTOANTIGEN;
BACTERIUM ANTIBODY;
BILIRUBIN;
GP2 ANTIBODY;
HEMOGLOBIN;
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN G ANTIBODY;
INFLIXIMAB;
MEMBRANE PROTEIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ZYMOGEN GRANULE;
ANTIBODY BLOOD LEVEL;
ANTIBODY DETECTION;
ANTIBODY TITER;
BILIRUBIN BLOOD LEVEL;
CLINICAL EVALUATION;
CLINICAL FEATURE;
COHORT ANALYSIS;
CONTROLLED STUDY;
CROHN DISEASE;
DISEASE ASSOCIATION;
DISEASE MARKER;
ENTERITIS;
GASTROINTESTINAL DISEASE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
POPULATION RESEARCH;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN LOCALIZATION;
REFERENCE VALUE;
SERODIAGNOSIS;
STANDARD;
TREATMENT DURATION;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
ULCERATIVE COLITIS;
ANIMALS;
AUTOANTIBODIES;
AUTOANTIGENS;
CROHN DISEASE;
FEMALE;
HUMANS;
MALE;
MEMBRANE GLYCOPROTEINS;
PANCREAS;
|
EID: 83555177630
PISSN: 00175749
EISSN: 14683288
Source Type: Journal
DOI: 10.1136/gut.2010.233148 Document Type: Letter |
Times cited : (48)
|
References (3)
|